$HALO Recent Headlines A Morgan Stanley buy, Alcoa's

New Post Public Reply Private Reply Replies (0) Message Board

Jan 10, 2014 at 9:34 PM

$HALO Recent Headlines

A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 8:40 a.m. Sept. 21, 2012 - Greg Morcroft
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 10:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme rebounds 10% in morning action 9:52 a.m. Aug. 3, 2012 - Val Brickates Kennedy
FDA seeks more data on Baxter, Halozyme drug 11:24 a.m. Aug. 2, 2012 - MarketWatch.com
Halozyme plunges 50% on FDA setback 9:47 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Halozyme plunges 50% on FDA setback 9:33 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 1:34 p.m. April 16, 2012 - MarketWatch
Baxter slides 6% on FDA setback 10:45 a.m. April 16, 2012 - Val Brickates Kennedy
Halozyme tumbles 27% on FDA setback 10:45 a.m. April 16, 2012 - Val Brickates Kennedy

Everything You Need to Know About Biotech M&A in a Single Chart 10:14 a.m. Jan. 7, 2014 - TheStreet.com
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
22 Biotech Stock Predictions for 2014 7:58 a.m. Jan. 6, 2014 - TheStreet.com
BioPharma Catalyst And Investment Pick In Focus: Synergy Pharma 8:15 a.m. Jan. 2, 2014 - Seeking Alpha
Commit To Purchase Halozyme Therapeutics At $10, Earn 14.5% Using Options 11:08 a.m. Dec. 31, 2013 - TheStreet.com
Is There Still Room To Profit With Halozyme? 12:52 p.m. Dec. 27, 2013 - Seeking Alpha
Halozyme Therapeutics (HALO) Jumps: Stock Up 16.6% - Tale of the Tape 8:51 a.m. Dec. 19, 2013 - Zacks.com
Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond 8:01 a.m. Dec. 19, 2013 - Seeking Alpha
UPDATE: Halozyme Spikes Higher on Positive CNBC Comments 11:56 a.m. Dec. 18, 2013 - benzinga.com
Cramer's Lightning Round - Not Being Two-Faced About Facebook (12/5/13) 6:44 a.m. Dec. 6, 2013 - Seeking Alpha
Halozyme Therapeutics' CEO Presents at Piper Jaffray Healthcare Conference (Transcript) 4:38 p.m. Dec. 3, 2013 - Seeking Alpha
Halozyme Therapeutics (HALO) Reaches New Lifetime High Today 9:46 a.m. Nov. 22, 2013 - TheStreet.com
10-Q: HALOZYME THERAPEUTICS INC 4:37 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Halozyme Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript 12:03 p.m. Nov. 8, 2013 - Seeking Alpha
Today's Dead Cat Bounce Stock: Halozyme Therapeutics (HALO) 9:47 a.m. Nov. 8, 2013 - TheStreet.com
ViroPharma's Core Business Is Accelerating, New Opportunities Emerge 11:33 a.m. Nov. 6, 2013 - Seeking Alpha
Halo's Shares Should Continue To Climb 8:30 a.m. Nov. 6, 2013 - Seeking Alpha
Halozyme's Shares Should Continue To Climb 8:30 a.m. Nov. 6, 2013 - Seeking Alpha
ViroPharma Beats by a Penny - Analyst Blog 9:10 a.m. Nov. 1, 2013 - Zacks.com
Important Catalysts Approaching For These Biotechs 7:55 a.m. Oct. 22, 2013 - Seeking Alpha

Halozyme Therapeutics To Present At The 32nd Annual J.P. Morgan Healthcare Conference 4:15 p.m. Jan. 9, 2014 - PR Newswire
Healthcare Conference Schedules and Additional Loans - Research Report on Clovis Oncology, LifePoint, Halozyme, Infinity, and Endologix 8:00 a.m. Jan. 9, 2014 - PR Newswire
Halozyme Secures Additional $20 Million Term Loan 9:00 a.m. Jan. 6, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Portfolio Expansions, Product Data, and Announcements by Healthcare Companies - Research Report on Life Technologies, OncoMed, Halozyme Therapeutics, Infinity, and PTC Therapeutics 8:00 a.m. Dec. 19, 2013 - PR Newswire
Intrexon Strengthens Leadership in Company's Rapidly Growing Health Sector 4:35 p.m. Dec. 17, 2013 - PR Newswire
Halozyme Therapeutics Announces Executive Transitions 4:30 p.m. Dec. 17, 2013 - PR Newswire
Dividends, FDA Approved Treatments, Clinical Data Presentations and Completed License Applications - Research Report on Medtronic, Auxilium, Alnylam, Infinity, and Halozyme 8:00 a.m. Dec. 11, 2013 - PR Newswire
Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis 8:00 a.m. Dec. 3, 2013 - PR Newswire
Baxter Submits Amended BLA to U.S. FDA for HyQvia for Primary Immunodeficiency 9:00 a.m. Dec. 2, 2013 - BusinessWire
Market Expert Opinion: Gilead Sciences, NPS Pharma, InterMune, and Halozyme Therapeutics 8:40 a.m. Dec. 2, 2013 - PR Newswire
Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 4:15 p.m. Nov. 26, 2013 - PR Newswire
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Halozyme Reports Third Quarter 2013 Financial Results 8:02 a.m. Nov. 8, 2013 - PR Newswire
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 6, 2013 - PR Newswire
Quarterly Dividends, Financial Results, and FDA Guidance - Research Report on Techne, ImmunoGen, Repros, Halozyme, and Synageva 8:00 a.m. Nov. 6, 2013 - PR Newswire
Under AAAResearchReports.com Microscope: Gilead Sciences Inc., NPS Pharma Inc., Halozyme Therapeutics Inc., and InterMune Inc. 11:14 a.m. Nov. 4, 2013 - PR Newswire
Halozyme to Host Third Quarter 2013 Financial Results Conference Call 9:00 a.m. Nov. 1, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Frederick Foundation Welcomes New Leaders for Growth

Stirring the Philanthropic Pot in Frederick Moving pieces around the community chessboard once again, the Community Foundation of Frederick County brings in fresh minds—and the stakes have never been higher for these charitable endeavors. They've just put RaeAnn E. Butler at the helm, an established presence who’s now the primary captain steering this ship. Come...

Milton Hershey School's New Project: Founders Grove Launches

Breaking New Ground with Founders Grove It’s not every day a community gets a new lease on life through bricks and mortar, but Milton Hershey School (MHS) just did exactly that. They've broken ground on Founders Grove, a piece of the Hershey West End development puzzle that reflects both history and future potential. This isn’t just another housing project—this...

Tiana Marbuery Joins ALTA Division at Partner

Tiana Marbuery Dives In at Partner Forget flashy office parties and buzzword bingo. Today’s gig's all about substance. Partner Engineering and Science, Inc. just snagged themselves a heavy-hitter with Tiana Marbuery joining the ranks as Technical Director in their ALTA Division. This ain't a small fry deal—Marbuery's packing over eight years of hard-earned chops in...

SAGA Metals Enters Decision-Making Circles in Canada

Stepping into the Big Leagues Seems like SAGA Metals is making a gutsy move, stepping into some heavy-hitting circles. They just hitched their wagon to the Canadian Chamber of Commerce's Critical Minerals Council. That's not just a foot in the door; that's walking right into the room where national policy gets cooked up. Joining forces here could be their ticket to...

Lifeway Kefir Hits Broadcasters with Football Flair

Kefir Goes Prime Time in Chicago Lifeway Foods, Inc. is stepping up its game with a splashy debut on Chicago's television scene. Just days after announcing the move, the leading player in the kefir industry is rolling out an ad campaign featuring none other than celebrated football stars Colston Loveland and D'Andre Swift. This isn't just any run-of-the-mill commercial...

Tech Job Market Surges with AI and IT Skills Spike

Alright, folks, though we're not drowning in champagne just yet, there's a promising uptick in October's tech employment, signaling a rebound or at least some relief for tech pros and market watchers. CompTIA's numbers show a boost of 7,200 jobs in the tech industry while IT occupations expanded by 26,000 slots. That's no small feat when the general job scene elsewhere...

INOVIO's $75M Offering: A Tough Medicine for Investors

A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...

Reliving the Legacy of Friendship at Friends & Co

Reconnecting With History In an era dominated by fleeting digital interactions, the heartening effort by Friends & Co stands out. This nonprofit is digging back into its roots and asking folks to share tales of the deep bonds formed over the past fifty years under its former guise, Little Brothers – Friends of the Elderly Twin Cities. The mission? To celebrate...

Trucordia Expands BYU Sponsorship with Helmet Branding

Trucordia Gets Visible with BYU Football Alright, BYU fans and insurance buffs, here's your latest play-by-play. Trucordia, a major player in the insurance game, is ratcheting up its visibility in the college sports scene. They've struck gold with a multiyear sponsorship deal putting their logo on Brigham Young University's (BYU) football helmet bumpers. Talk about a...

Dr. Lachlan Forrow Honored with ASF Lifetime Achievement Award

Championing a Legacy of Compassion in Medicine Listen up: not every day you hear about someone leading healthcare with a soul. Here's Dr. Lachlan Forrow, celebrated by the Albert Schweitzer Fellowship for shaping bioethics and medical humanism for over forty years. This fella's carved out a niche that melds heart with healthcare, and that's why he's scoring the inaugural...